Citigroup »

Calidi Biotherapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Calidi Biotherapeutics (CLDI) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Calidi Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Calidi Biotherapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Calidi Biotherapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $3 14 0.21

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Calidi Biotherapeutics

Armistice Capital
Warberg Asset Management
HighTower Advisors
Geode Capital Management
Rs Crum
SRS Capital Advisors
Jane Street
Vanguard Group
Vanguard Capital Management
FMR
Virtu Financial
Belpointe Asset Management
Northern Trust
Hrt Financial
Farther Finance Advisors

View all funds holding Calidi Biotherapeutics